Poster 101: Overexposure to voriconazole associated with inflammation
| Play Video Presentation |  View Poster |
View Abstract | Email Presenter |
Poster 102: Uracil-Dihydrouracil metabolism and DPYD polymorphisms as factors in the determination of 5-Fluorouracil-induced toxicity in Thai colorectal cancer patients
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 103: Clinical Utility of High-Resolution Mass Spectrometry in a Pediatric Case of Altered Mental Status
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 104: Capillary sampling is suitable for high-throughput remote therapeutic drug monitoring for biologics
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 105: Medication Optimization Based On Pharmacogenetic Panel Testing In A Clinical Setting – The Guide On Med Research
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 106: Integration of genomics, clinical characteristics and baseline biological profiles to predict the risk of liver injury induced by high-dose methotrexate
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 107: Increased plasma exposure and toxicity to imatinib in chronically treated GIST patients with SARS-CoV-2 infection: a case-series
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 108: Therapeutic drug monitoring of mycophenolic acid (MPA) in renal transplant pediatric patients– clinical laboratory perspective
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 109: Clinical Comparison of Emit And QMS Assays with LC-MS/MS Method For Methotrexate Determination – Application For Therapeutic Drug Monitoring
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 110: LC-MS/MS Analysis of mAbs Using a Monoclonal Antibodies Quantification Kit – Spotlight on Infliximab
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 111: Analysis of Cannabinoids by Isomer-Selective UPLC-MS-MS Analysis in Urine for Clinical Research
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 112: Development and validation of an LC-MS/MS method for simultaneous determination of iohexol and creatinine for GFR estimation in cats using VAMS samples
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 113: Therapeutic drug monitoring (TDM) of Carboplatin (CRB) during tandem high-dose chemotherapy (HDCT) and peripheral-blood stem-cell rescue as salvage treatment of a child with relapsed germ cell tumor (GCT)
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 114: Synthetic cathinones in drug-facilitated sexual assault: a case report involving the novel generation substituted cathinone N-ethylpentedrone
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 115: Clinical trial simulations to assess the influence of population pharmacokinetic model selection on initial dosing recommendations of vancomycin in neonates
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 116: Evaluation of the immunosuppressive drugs metabolism, CYP450 and UGT activity by the liver graft using an ex-vivo porcine livers model
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 117: Effect of fecal microbiota transplantation on CYP3A activity in patients with systemic sclerosis
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 118: Quantitation of an Oral Fluid Drug Panel Including THC Using High Resolution Accurate-Mass (HRAM) Orbitrap Mass Spectrometry
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 119: Improved Specificity for Targeted LC-MS/MS Measurements of 2,3-dinor-11β-Prostaglandin F2α in Urine using FAIMS Technology
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 120: Individualization of Piperacillin Dosage in a Tertiary Care Centre: Benefits of Therapeutic Drug Monitoring With or Without Model-Informed Precision Dosing
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 121: Nitrite dipstick urinalysis, a potential method for point-of-care testing in sodium nitrite poisoning
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 123: Antipsychotic Drug Stability in Serum and Plasma Patient Samples
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 124: Novel TDM strategy; Inhaled breath as an alternative matrix in TDM for inhalation medicine
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 125: Advancing pharmacometrics with a new open-source framework for pharmacokinetic modelling
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 126: Historical individual Bayesian estimates improve model predictions in repeat vancomycin courses
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 127: Evaluation of target area under the concentration-time curve of vancomycin in an initial dosing design: a single-center retrospective cohort study
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 128: Interference of fulvestrant in the determination of plasma immunoreactive levels of estradiol: a single-center experience with monitoring of treated breast cancer patients and with the transition to a new immunoassay.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 129: Retrospective evaluation of pathogenic genetic findings with potential association to late treatment toxicities from a large observational study on long-term breast cancer survivors
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 130: Relationship between trough ganciclovir concentration and leukopenia in lung transplant recipients receiving valganciclovir prophylaxis
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 131: Investigation of False Positives in CEDIA Buprenorphine Assay in Urine Drug Screening
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 132: Population pharmacokinetics of clozapine in schizophrenia patients: sex differences and impact of fluvoxamine coadministration
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 133: LC-MS/MS DETERMINATION OF RAPAMYCIN (SIROLIMUS) IN WHOLE BLOOD AND VOLUMETRIC ABSORPTIVE MICROSAMPLES – ASSESSMENT OF THERAPEUTIC DRUG MONITORING IN IMMUNOSUPPRESSIVE THERAPY AND COMPARISON WITH APPLICATIONS OF IMMUNOCHEMICAL TECHNIQUES
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 134: Therapeutic drug monitoring of selected antibiotics using the volumetric absorptive-microsampling device (VAMS) in the pediatric population with sepsis: bioanalytical and pharmacokinetic aspects of ANTISEPSIS study
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 135: THERAPEUTIC DRUG MONITORING OF CYCLOSPORINE A IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS USING VOLUMETRIC ABSORPTIVE MICROSAMPLING WITH LC-MS/MS TECHNIQUE – CROSS- AND CLINICAL VALIDATION OF THE BIOANALYTICAL METHOD
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 136: Determination of dronedarone and debutyldronedarone in plasma by HPLC-UV
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 137: AUC of Micophenolate mofetil as a tool to avoid over and under exposure.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 138: Assessment of trace metal contamination in blood collection tubes and storage containers for human biomonitoring studies
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 139: A simple LC-MS/MS method for ganciclovir determination in dried plasma collected by Mitra™-VAMS and its application in pediatric renal transplant recipients and neonates
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 140: Evaluation of the impact of missing a dose of mycophenolate mofetil based on population pharmacokinetic modeling and proposition of a mitigation strategy
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 141: Population pharmacokinetic model and Bayesian estimation of mycophenolic acid AUC in patients on enteric-coated mycophenolate sodium
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 142: Quantification of midostaurin in plasma and serum by stable isotope dilution liquid chromatography-tandem mass spectrometry: Application to a cohort of patients with acute myeloid leukemia
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 143: Obesity and augmented renal clearance influence cefiderocol PK/PD target attainment in critically ill patients.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 144: Exploration of endogenous biomarker candidates for evaluating organic anion transporting polypeptide 1B3 (OATP1B3) activity in Japanese general adults using untargeted metabolomics analysis approach
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 145: External evaluation of intravenous vancomycin population pharmacokinetics models in adults receiving high-flux intermittent hemodialysis
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 146: Can we predict saliva penetration of drugs? A systematic review
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 147: Elucidation of the mechanism of gefitinib-induced immune related adverse reaction and search for biomarkers to predict its pathogenesis
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 148: Search for novel biomarkers indicating cytochrome P450 3A5 activity using untargeted metabolomics
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 149: Prediction accuracy of amikacin population pharmacokinetic models in Japanese pediatric patients
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 150: Six-hourly dosing of intravenous vancomycin is not required for adolescents aged 12 years and above
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 152: Metabolic reprogramming supporting the high proliferation of erythroblasts during ineffective erythropoiesis in β-thalassemia/Hb E disease
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 153: Development of a LC-MS/MS method for quantitation of 5FU from Telimmune ® cards for the purpose of therapeutic drug monitoring
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 154: Pharmacokinetic Analysis of Antipsychotics in Elderly Patients with Delirium Using Nonlinear Mixed-Effects Modeling
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 155: High Sensitivity Homogeneous Enzyme Immunoassay for Benzodiazepines and Metabolites
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 156: Sensitive and Rapid Homogeneous Immunoassay for the Detection of Zolpidem and its Major Metabolite in Urine
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 157: DIAGNOSTIC ACCURACY OF AN IMMUNOMETRIC METHOD FOR TOXICOLOGICAL SCREENING ON URINARY MATRIX ACCORDING TO CLSI EP12-A2 GUIDELINE
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 158: Use of therapeutic drug monitoring for continuous ampicillin therapy of critically ill patients
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 159: A fatal case of food poisoning of cucurbitacin containing courgette.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 160: Sensitive quantification of free lenvatinib using ultra-high performance liquid chromatography coupled to tandem mass spectrometry and assessment for clinical application.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 161: From venous blood to VAMS – adaptation of a commercial CE-IVD assay kit for the determination of Tacrolimus, Sirolimus, Everolimus and Cyclosporin A.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 162: Increased intestinal permeability in rats with portal hypertension-associated right heart failure
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 163: PK/PD modeling of amoxicillin/clavulanic acid in vitro effects on bacterial growth and killing and in vivo exposure evaluation in young pediatric patients.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 164: BUSULFAN THERAPEUTIC DRUG MONITORING (TDM) FOR CONDITIONING REGIMEN IN PAEDIATRIC HSCT PATIENTS TO ACHIEVE RECENTLY HARMONIZED CUMULATIVE EXPOSURE (cAUC): A RETROSPECTIVE ANALYSIS RESULTS OF SINGLE CENTRE
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 165: Comparing two-sample log-linear exposure estimation with Bayesian model-informed precision dosing of tobramycin in adult patients with cystic fibrosis
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 166: Population Pharmacokinetics of Vancomycin in Term Neonates with Perinatal Asphyxia treated with Therapeutic Hypothermia.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 167: Analytical imprecision goals for immunosuppressive drugs: A retrospective study and comparison of four alternative approaches
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 168: Limited sampling on model-informed precision dosing of daptomycin for rapidly achieving target area under the concentration–time curve: A simulation study
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 169: POTENTIAL APPLICATION OF INFLIXIMAB TDM AND BIOMARKER MONITORING IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS: A RETROSPECTIVE REAL-WORLD COHORT STUDY
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 170: A Sensitive and Validated HPLC-UVMethod for the Quantitative Analysis of Sulfamethoxazole in Human Plasma: Application in TDM for PJP Patients
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 171: Determination of Urinary 1-Hydroxypyrene in Wildland Firefighters
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 172: Plasma Proteomics Study on Pharmacokinetic Variability of Tacrolimus in Liver Transplant Recipients
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 173: Pharmacokinetics and pharmacodynamics of a simplified fixed dose of polymyxin B in critically ill patients with extensive drug-resistant Gram-negative bacteria–induced nosocomial pneumonia
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 301: Clinical Evaluation of Lamotrigine and Levetiracetam Therapeutic Drug Monitoring in Pregnant Women with Epilepsy
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 302: Clinical Utility of a High-Resolution Mass Spectrometry-Based Comprehensive Drug Screen Assay in the Emergency Medicine Setting
Poster 303: Preliminary results of the PERFU study: PERsonalized predication and regulation of 5-FluoroUracil exposure
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 304: Association of Busulfan Exposure and Outcomes after Hematopoietic Cell Transplantation for Patients with an Inborn Error of Immunity
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 305: Pharmacokinetic-Pharmacodynamic Model of Unfractionated Heparin and aPTT From Real-World Adult Clinical Data
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 306: Thiopurine drugs, therapeutic drug monitoring by quantification drug metabolites or measure incorporation into DNA as deoxythioguanosine.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 307: Ethanol, ethyl glucuronide (EtG) and ethyl sulphate (EtS) in blood and urine after controlled drinking.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 308: Therapeutic drug monitoring of selected antiviral and antifungal agents using the volumetric absorptive-microsampling device (VAMS) in the pediatric population with sepsis: bioanalytical aspects of ANTISEPSIS study
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 309: A SIMPLE HPLC-UV METHOD FOR 6-THIOGUANINE DETERMINATION IN RED BLOOD CELLS DURING PHARMACOTHERAPY WITH AZATHIOPRINE – APPLICATION TO THERAPEUTIC DRUG MONITORING IN CLINICAL PRACTICE
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 310: Rapid Analysis of Clozapine and Norclozapine in Plasma for Clinical Research
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 311: The Analysis of Tricyclic Antidepressant Drugs in Plasma for Clinical Research
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 312: Rapid Quantification of the Cytotoxic Drug, Busulfan, in Plasma for Rapid Dose Adjustment by Laser Diode Thermal Desorption (LDTD)-MS/MS
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 313: Falsely elevated calcineurin-inhibitor trough levels: a case series of catheter adsorption
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 314: Bayesian Estimation of Vancomycin AUC0-24 in an Adult Population with Hematologic Cancer: What Would Be the Best Sampling Strategy?
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 315: Population pharmacokinetic model for intracellular and whole blood tacrolimus in liver transplant recipients
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 316: Exploring the Relationship Between Ceftriaxone Plasma Concentrations and Neurotoxicity in Critically Ill Patients: An Ongoing Multicenter Retrospective Cohort Study
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 317: Development and validation of an LC-MS/MS method for TDM of Osimertinib and its metabolites AZ7550 and AZ5104 in plasma
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 318: Utilizing HRAM Orbitrap MS to Quantify Therapeutic Monoclonal Antibodies (mAbs) in Human Serum for Clinical Research
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 319: History, current status and future of psychiatric therapeutic drug monitoring in China
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 321: Dolutegravir discontinuation due to neuropsychiatric adverse events: a pharmacogenetic case-control study.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 322: Determination of 25-hydroxyvitamin D3 in dried blood spots: are we there yet?
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 323: Equivalence of Venous and Capillary Point-of-Care Clozapine Levels
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 324: Retention of sensitivity of a disposable sensor using molecularly imprinted carbon paste to vancomycin in human serum.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 325: Clinical Impact of Implementing Urine Fentanyl Testing in A Safety Net Healthcare System
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 326: Population pharmacokinetic analysis of caffeine in preterm infants considering pre- and postnatal period
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 327: A single-center experience on tolerance to chemotherapy with adjusted dosing of capecitabine in breast cancer patients with altered variants in the dihydropyrimidine dehydrogenase gene.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 328: Toxicity and managing issues with antibody-drug conjugates and last-generation approved kinase inhibitors for breast cancer in patients with suspected Gilbert´s disease
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 329: Improvement of simulated PK data-based machine learning model with real-world data to predict infliximab pharmacokinetics in pediatric patients with Crohn’s disease
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 330: Analysis of Antimycotics in Serum / Plasma Using RECIPE® ClinMass® TDM Kit with Fully Automated Sample Preparation LC/MS/MS System
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 331: DEVELOPMENT AND EVALUATION OF I-TRACKER BELATACEPT AND I-TRACKER ANTI-BELATACEPT KITS: FAST AND INNOVATIVE CHEMILUMINESCENT ASSAYS FOR THE MONITORING OF PATIENTS TREATED WITH BELATACEPT
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 332: Therapeutic drug monitoring of apixaban using volumetric-absorptive microsampling and LC-MS/MS technique – method development, validation and clinical application
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 333: Concomitantly determination of mycophenolic acid (MPA), tacrolimus (TAC) and creatinine (CRE) in saliva using LC-MS/MS– analytical method development, validation and clinical application
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 334: The heterogeneity of pediatric oncological patients treated with selumetinib
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 335: Plasma Venetoclax Concentrations in Patients with Acute Myeloid Leukemia (AML) Treated with Cytochrome P450 3A4 (CYP3A4) Inhibitors
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 336: Mycophenolic acid exposure in liver transplant recipients
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 338: Cannabinoids levels description in a cohort of patients with chronic and neuropathic pain treated with Medical Cannabis: a possible role of TDM
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 339: Simultaneous pancreas kidney recipients have a lower tacrolimus exposure for a similar c0 as compared to kidney only recipients
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 340: Optimization of antimicrobial therapy through therapeutic drug monitoring and pharmacometric expertise: two case reports
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 341: Missed or delayed doses of extended-release tacrolimus in transplantation: impact on exposure and mitigation strategies
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 342: Feasibility of infliximab point-of-care-testing in clinical practice
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 343: Evaluating the incidence of acute kidney injury and tacrolimus dosing regimen in heart transplant recipients receiving basiliximab induction therapy.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 344: Rapid identification and quantification of performance-enhancing stimulants in human urine using high-resolution mass spectrometry
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 345: Pharmacokinetic modelling to predict the metabolic saturation of voriconazole in paediatrics with life-threatening invasive fungal infections
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 346: Is saliva-based therapeutic drug monitoring feasible? A systematic review
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 347: Cost-Efficiency and optimization of cefiderocol dosing: Insights from population pharmacokinetic/pharmacodynamic simulation.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 348: Elucidation of the mechanism of amiodarone-induced immune related adverse reaction and search for biomarkers to predict its pathogenesis
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 349: Development of a Flexible Vancomycin Sensor Using A Molecularly Imprinted Polymer Carbon Paste
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 350: PFAS in Me: Which Ones and How Much?
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 351: MYCOPHENOLIC ACID TROUGH LEVEL IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES – PILOT STUDY
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 352: Therapeutic monitoring of CDK4/6is using DBS: an LC-MS/MS method to overcome the haematocrit effect
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 353: Rapid and reliable quantification of six antipsychotic drugs in serum
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 354: Evaluation of Vancomycin Pharmacokinetic Model for Pediatric Cancer Population
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 355: Homogeneous Enzyme Immunoassay for Xylazine and Its Metabolites
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 356: Baseline characteristics of the BeNeBio cohort: Dose Reduction of the New Generation Biologics (IL-17 and IL-23 Inhibitors) in Psoriasis: a Pragmatic, Multicentre, Randomized, Controlled, Non-inferiority Study
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 357: Using real-world data: Can CYP2C19 genotype predict an individuals’ response to voriconazole?
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 358: Seventeen drugs, one sample: analyzing multiple anti-tuberculosis drugs simultaneously using one method.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 359: Paracetamol half-life declines over time following an acute overdose.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 360: Determinants of erythrocyte methotrexate polyglutamate concentrations in patients treated with methotrexate
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 361: VAMS – what are the best transport and storage conditions? A case study.
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 362: The mechanism of flutamide induced liver injury via inflammasome activation
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 363: Determination of Posaconazole in Human Serum: Enhancing Therapeutic Drug Monitoring in Hematopoietic Stem Cell Transplantation (HSCT) Recipients
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 365: Sorafenib activates inflammasomes leading to sorafenib-induced immune related adverse events
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 366: Tackling the preanalytical instability of dihydropyrimidine dehydrogenase phenotyping via dried blood microsampling
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 367: Evaluation of a high loading dose regimen of teicoplanin in children
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 368: Validating an LC-MS/MS Method for the Inclusion of Bromazolam Screening in Routine Urine Drug Tests
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 369: 24/7 fully automated therapeutic drug analysis for research projects by LC/MS/MS
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 370: Utilizing LC-HRMS for the Identification of Protonitazene and Its Metabolites in Urine
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 371: Therapeutic drug monitoring of imatinib in Chinese gastrointestinal stromal tumour patients by an HPLC method
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 373: Quantitation of Panel of Per- and Polyfluoroalkyl Substances (PFAS) in Biological Matrix
| Play Video Presentation | View Poster | View Abstract | Email Presenter |
Poster 374: Quantification of ceftazidime in vitreous humor using ultra-performance convergence chromatography-tandem mass spectrometry
| Play Video Presentation | View Poster | View Abstract | Email Presenter |